BAH vs INCY
Booz Allen Hamilton Holding Corp. and Incyte Corp., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | BAH | INCY |
|---|---|---|
| Revenue | $11.2B | $5.1B |
| Net income | $851.0M | $1.3B |
| Gross margin | 52.7% | 92.8% |
| Net margin | 7.6% | 25.0% |
| Return on equity | 80.7% | 29.9% |
| Diluted EPS | $6.90 | $6.41 |
| Dividend / share | $2.24 | · |
| Payout ratio | 32.4% | · |
| Free cash flow | $951.0M | · |
| Equity | $1.1B | $5.2B |
| Net debt / equity | 2.91× | · |
| Current ratio | 1.78× | 3.32× |
| Revenue CAGR 5y | 7.4% | 14.0% |
| Profit CAGR 5y | 6.9% | · |
BAH bills 2.2× the revenue of INCY, and INCY keeps more of each dollar of revenue as profit (25.0% against 7.6%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | BAH | INCY |
|---|---|---|
| FY2025 | $11.2B | $5.1B |
| FY2024 | $12.0B | $4.2B |
| FY2023 | $10.7B | $3.7B |
| FY2022 | $9.3B | $3.4B |
| FY2021 | $8.4B | $3.0B |
| FY2020 | $7.9B | $2.7B |
| FY2019 | $7.5B | $2.2B |
| FY2018 | $6.7B | $1.9B |
| FY2017 | $6.2B | $1.5B |
| FY2016 | $5.8B | $1.1B |
Bottom line
| Fiscal year | BAH | INCY |
|---|---|---|
| FY2025 | $851.0M | $1.3B |
| FY2024 | $935.0M | $32.6M |
| FY2023 | $606.0M | $597.6M |
| FY2022 | $272.0M | $340.7M |
| FY2021 | $466.7M | $948.6M |
| FY2020 | $609.0M | $-295.7M |
| FY2019 | $482.6M | $446.9M |
| FY2018 | $418.5M | $109.5M |
| FY2017 | $301.7M | $-313.1M |
| FY2016 | $260.8M | $104.2M |
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$6,075,758,000 | BAH |
| FY2024 | +$7,738,783,000 | BAH |
| FY2023 | +$6,966,351,000 | BAH |
| FY2022 | +$5,864,365,000 | BAH |
| FY2021 | +$5,377,433,000 | BAH |
| FY2020 | +$5,192,236,000 | BAH |
| FY2019 | +$5,305,082,000 | BAH |
| FY2018 | +$4,822,154,000 | BAH |
| FY2017 | +$4,631,384,000 | BAH |
| FY2016 | +$4,703,772,000 | BAH |
| FY2015 | +$4,651,987,000 | BAH |
| FY2014 | +$4,763,275,000 | BAH |
| FY2013 | +$5,123,746,000 | BAH |
| FY2012 | +$5,461,000,000 | BAH |
| FY2011 | +$5,764,763,000 | BAH |
| FY2010 | +$5,421,418,000 | BAH |
| FY2009 | +$5,113,368,000 | BAH |
BAH has reported the higher revenue in every one of these 17 fiscal years. The gap has widened since the earliest year compared.
17 of 17 comparable fiscal years — a year missing data on either side is not counted.
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −17.4 pp | INCY |
| FY2024 | +7.0 pp | BAH |
| FY2023 | −10.5 pp | INCY |
| FY2022 | −7.1 pp | INCY |
| FY2021 | −26.2 pp | INCY |
| FY2020 | +18.8 pp | BAH |
| FY2019 | −14.2 pp | INCY |
| FY2018 | +0.4 pp | BAH |
| FY2017 | +25.3 pp | BAH |
| FY2016 | −4.9 pp | INCY |
The higher net margin has changed hands between BAH and INCY over this period.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
INCY's net margin has been more volatile than BAH's over the 10 comparable fiscal years — 15.2 percentage points of standard deviation against 1.5.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between BAH and INCY over these 10 fiscal years — BAH led in 4 and INCY in 6.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
INCY's return on equity has been more volatile than BAH's over the 10 comparable fiscal years — 19.3 percentage points of standard deviation against 17.2.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
BAH led in return on equity in every one of the 10 comparable fiscal years — a structural lead, not a recent swing.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.